Bills › 2025–26 › SB 6228
BILL · 2025–26 SESSION · LATEST VERSION ESB 6228
SB 6228: Prescription drugs/taxes
Removing a tax exemption for the warehousing and reselling of prescription drugs. (REVISED FOR ENGROSSED: Removing a tax exemption for the warehousing and reselling of prescription drugs and providing tax relief for critical access pharmacies.)
Summary
Repeals the preferential business and occupation (B&O) tax rate for warehousing and reselling prescription drugs. Creates a preferential B&O tax rate for critical access pharmacies.
From the Engrossed House Bill Report (ESB 6228), written by the Legislature's nonpartisan staff. Read the full report ↗
Enacted Enacted · Chapter 265, Laws of 2026
IntroducedJan 20, 2026
Out of committeeFeb 23, 2026
Passed SenateFeb 28, 2026
Passed HouseMar 11, 2026
GovernorApr 1, 2026
LawApr 1, 2026
Introduced January 20, 2026 in the Senate
Last action April 1, 2026
Session law Chapter 265, Laws of 2026
Requested by State agency
Budget Has a fiscal note
Versions SB 6228, ESB 6228
Sponsors (3)
Votes (3)
History (26)
Official bill page & text ↗
AN ACT Relating to removing a tax exemption for the warehousing and reselling of prescription drugs and providing tax relief for critical access pharmacies;
Votes
Senate · 3rd Reading & Final Passage
Passed February 28, 2026
Version voted on: ESB 6228
25 Yea
23 Nay
0 Absent
1 Excused
Party Yea Nay Absent Excused
Democrat 25 4 0 1
Republican 0 19 0 0
How each member voted
House · Final Passage as Amended by the House
Passed March 11, 2026
Version voted on: ESB 6228
52 Yea
42 Nay
0 Absent
4 Excused
Party Yea Nay Absent Excused
Democrat 52 6 0 1
Republican 0 36 0 3
How each member voted
Senate · Final Passage as Amended by the House
Passed March 12, 2026
Version voted on: ESB 6228
26 Yea
23 Nay
0 Absent
0 Excused
Party Yea Nay Absent Excused
Democrat 26 4 0 0
Republican 0 19 0 0
How each member voted
History
Apr 1, 2026 Effective date 1/1/2027. (ESB 6228)
Apr 1, 2026 Chapter 265, 2026 Laws. (ESB 6228)
Apr 1, 2026 Governor signed. (ESB 6228)
Mar 13, 2026 Delivered to Governor. (ESB 6228)
Mar 12, 2026 Speaker signed. (ESB 6228)
Mar 12, 2026 Senate concurred in House amendments. (ESB 6228)
Mar 12, 2026 Passed final passage; yeas, 26; nays, 23; absent, 0; excused, 0. (ESB 6228)
Mar 12, 2026 President signed. (ESB 6228)
Mar 11, 2026 Third reading, passed; yeas, 52; nays, 42; absent, 0; excused, 4. (ESB 6228)
Mar 11, 2026 Rules suspended. Placed on Third Reading. (ESB 6228)
Mar 11, 2026 Committee amendment(s) adopted as amended. (ESB 6228)
Mar 9, 2026 Referred to Rules 2 Review. (ESB 6228)
Mar 9, 2026 Rules Committee relieved of further consideration. Placed on second reading. (ESB 6228)
Mar 7, 2026 Minority; do not pass. (ESB 6228)
Mar 7, 2026 FIN - Majority; do pass with amendment(s). (ESB 6228)
Mar 7, 2026 FIN - Executive action taken by committee. (ESB 6228)
Mar 3, 2026 First reading, referred to Finance. (ESB 6228)
Feb 28, 2026 Third reading, passed; yeas, 25; nays, 23; absent, 0; excused, 1. (ESB 6228)
Feb 28, 2026 Rules suspended. Placed on Third Reading. (ESB 6228)
Feb 28, 2026 Floor amendment(s) adopted. (ESB 6228)
Feb 27, 2026 Placed on second reading by Rules Committee. (ESB 6228)
Feb 23, 2026 Minority; without recommendation. (ESB 6228)
Feb 23, 2026 Minority; do not pass. (ESB 6228)
Feb 23, 2026 Passed to Rules Committee for second reading. (ESB 6228)
Feb 19, 2026 WM - Majority; do pass. (ESB 6228)
Jan 20, 2026 First reading, referred to Ways & Means. (ESB 6228)
SB 6228 in other sessions
Bill numbers restart every two years, so the same number is a different bill in each session.
Report wrong or missing information on this page